Christine Tyson

PhD

Investigator, BC Children's Hospital
Clinical Molecular Geneticist and Clinical Cytogeneticist, BC Children's Hospital

I use genetic and genomic technologies to investigate the genetic causes of developmental disorders such as autism, intellectual disability and other neurodevelopmental disorders.

Academic Affiliations

  • Clinical Professor, Genome Diagnostics, Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia
  • Research Theme: Brain, Behaviour & Development
  • Research Group(s): Neurodevelopmental and Neurological Disorders; Origins of Child Health and Disease; Rare Diseases

Contact Information

Location

4480 Oak Street, Vancouver, British Columbia, Canada, V6H 3V4

Genome-wide sequencing and the clinical diagnosis of genetic disease: The CAUSES study

Human Genetics and Genomics Advances

Elliott, A.M. and Adam, S. and du Souich, C. and Lehman, A. and Nelson, T.N. and van Karnebeek, C. and Alderman, E. and Armstrong, L. and Aubertin, G. and Blood, K. and Boelman, C. and Boerkoel, C. and Bretherick, K. and Brown, L. and Chijiwa, C. and Clarke, L. and Couse, M. and Creighton, S. and Watts-Dickens, A. and Gibson, W.T. and Gill, H. and Tarailo-Graovac, M. and Hamilton, S. and Heran, H. and Horvath, G. and Huang, L. and Hulait, G.K. and Koehn, D. and Lee, H.K. and Lewis, S. and Lopez, E. and Louie, K. and Niederhoffer, K. and Matthews, A. and Meagher, K. and Peng, J.J. and Patel, M.S. and Race, S. and Richmond, P. and Rupps, R. and Salvarinova, R. and Seath, K. and Selby, K. and Steinraths, M. and Stockler, S. and Tang, K. and Tyson, C. and van Allen, M. and Wasserman, W. and Mwenifumbo, J. and Friedman, J.M.

DOI: 10.1016/j.xhgg.2022.100108

A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8

Journal of Human Genetics

Yasin, H. and Gibson, W.T. and Langlois, S. and Stowe, R.M. and Tsang, E.S. and Lee, L. and Poon, J. and Tran, G. and Tyson, C. and Wong, C.K. and Marra, M.A. and Friedman, J.M. and Zahir, F.R.

DOI: 10.1038/s10038-019-0561-0

Copy number variation of the REXO1L1 gene cluster; Euchromatic deletion variant or susceptibility factor?

European Journal of Human Genetics

Barber, J.C.K. and Sharp, A.J. and Hollox, E.J. and Tyson, C.

DOI: 10.1038/ejhg.2016.104

A novel microdeletion affecting the CETP gene raises HDL-associated cholesterol levels

Clinical Genetics

Hitchcock, E. and Patankar, J.V. and Tyson, C. and Hrynchak, M. and Hayden, M.R. and Gibson, W.T.

DOI: 10.1111/cge.12633

Expansion of a 12-kb VNTR containing the REXO1L1 gene cluster underlies the microscopically visible euchromatic variant of 8q21.2

European Journal of Human Genetics

Tyson, C. and Sharp, A.J. and Hrynchak, M. and Yong, S.L. and Hollox, E.J. and Warburton, P. and Barber, J.C.K.

DOI: 10.1038/ejhg.2013.185

Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: The role of provincial laboratory standardization

Cancer Genetics

Gerrie, A.S. and Huang, S.J.T. and Bruyere, H. and Dalal, C. and Hrynchak, M. and Karsan, A. and Ramadan, K.M. and Smith, A.C. and Tyson, C. and Toze, C.L. and Gillan, T.L.

DOI: 10.1016/j.cancergen.2014.08.006

Clinical application of 2.7M Cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disability

Clinical Genetics

Qiao, Y. and Tyson, C. and Hrynchak, M. and Lopez-Rangel, E. and Hildebrand, J. and Martell, S. and Fawcett, C. and Kasmara, L. and Calli, K. and Harvard, C. and Liu, X. and Holden, J.J.A. and Lewis, S.M.E. and Rajcan-Separovic, E.

DOI: 10.1111/j.1399-0004.2012.01860.x

Genotype-phenotype analysis of 18q12.1-q12.2 copy number variation in autism

European Journal of Medical Genetics

Wang, P. and Carrion, P. and Qiao, Y. and Tyson, C. and Hrynchak, M. and Calli, K. and Lopez-Rangel, E. and Andrieux, J. and Delobel, B. and Duban-Bedu, B. and Thuresson, A.-C. and Annern, G. and Liu, X. and Rajcan-Separovic, E. and Suzanne Lewis, M.E.

DOI: 10.1016/j.ejmg.2013.05.006

Understanding the impact of 1q21.1 copy number variant

Orphanet Journal of Rare Diseases

Harvard, C. and Strong, E. and Mercier, E. and Colnaghi, R. and Alcantara, D. and Chow, E. and Martell, S. and Tyson, C. and Hrynchak, M. and McGillivray, B. and Hamilton, S. and Marles, S. and Mhanni, A. and Dawson, A.J. and Pavlidis, P. and Qiao, Y. and Holden, J.J. and Lewis, S.M.E. and O'Driscoll, M. and Rajcan-Separovic, E.

DOI: 10.1186/1750-1172-6-54

Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics

Human Genetics

Qiao, Y. and Harvard, C. and Tyson, C. and Liu, X. and Fawcett, C. and Pavlidis, P. and Holden, J.J.A. and Lewis, M.E.S. and Rajcan-Separovic, E.

DOI: 10.1007/s00439-010-0837-0

Identification of copy number variants in miscarriages from couples with idiopathic recurrent pregnancy loss

Human Reproduction

Rajcan-Separovic, E. and Diego-Alvarez, D. and Robinson, W.P. and Tyson, C. and Qiao, Y. and Harvard, C. and Fawcett, C. and Kalousek, D. and Philipp, T. and Somerville, M.J. and Stephenson, M.D.

DOI: 10.1093/humrep/deq202

Genomic changes detected by array CGH in human embryos with developmental defects

Molecular Human Reproduction

Rajcan-Separovic, E. and Qiao, Y. and Tyson, C. and Harvard, C. and Fawcett, C. and Kalousek, D. and Stephenson, M. and Philipp, T.

DOI: 10.1093/molehr/gap083

Molecular cytogenetic investigation of two patients with Y chromosome rearrangements and intellectual disability

American Journal of Medical Genetics, Part A

Tyson, C. and Dawson, A.J. and Bal, S. and Tomiuk, M. and Anderson, T. and Tucker, D. and Riordan, D. and Chudoba, I. and Morash, B. and Mhanni, A. and Chudley, A.E. and McGillivray, B. and Parslow, M. and Rappold, G. and Roeth, R. and Fawcett, C. and Qiao, Y. and Harvard, C. and Rajcan-Separovic, E.

DOI: 10.1002/ajmg.a.32535

Submicroscopic deletions of 11q24-25 in individuals without Jacobsen syndrome: re-examination of the critical region by high-resolution array-CGH

Molecular Cytogenetics

Christine Tyson and Ying Qiao and Chansonette Harvard and Xudong Liu and Francois P Bernier and Barbara McGillivray and Sandra A Farrell and Laura Arbour and Albert E Chudley and Lorne Clarke and William Gibson and Sarah Dyack and Ross McLeod and Teresa Costa and Margot I VanAllen and Siu-li Yong and Gail E Graham and Patrick MacLeod and Millan S Patel and Jane Hurlburt and Jeanette JA Holden and Suzanne ME Lewis and Evica Rajcan-Separovic

DOI: 10.1186/1755-8166-1-23

Submicroscopic deletions and duplications in individuals with intellectual disability detected by Array-CGH

American Journal of Medical Genetics

Tyson, C. and Harvard, C. and Locker, R. and Friedman, J.M. and Langlois, S. and Lewis, M.E.S. and Van Allen, M. and Somerville, M. and Arbour, L. and Clarke, L. and McGilivray, B. and Yong, S.L. and Siegel-Bartel, J. and Rajcan-Separovic, E.

DOI: 10.1002/ajmg.a.31015

Elucidation of a cryptic interstitial 7q31.3 deletion in a patient with a language disorder and mild mental retardation by array-CGH

American Journal of Medical Genetics

Tyson, C. and McGillivray, B. and Chijiwa, C. and Rajcan-Separovic, E.

DOI: 10.1002/ajmg.a.30245

Analysis of proximal X chromosome pairing in early female mouse meiosis

Chromosoma

Christine O'Keeffe and Maj A. Hultn and Charles Tease

DOI: 10.1007/s004120050248

09 / 1997

The MAGERS Study

The MAGERS study is an innovative, intensive pilot exploration of treatment-resistant/refractory psychosis using three complementary, cutting-edge genomics technologies (whole exome sequencing, chromosomal microarray screening, and gene expression profiling), and both extended clinical biochemical screens as well as investigational metabolomics aimed at identifying high-penetrance genomic risk variants in schizophrenia, including those causing inborn errors of metabolism. The hope is to identify mechanisms of symptom production and treatable metabolic disorders that may lead to more effective and better-tolerated treatment for individuals suffering with treatment-resistant/refractory schizophrenia and schizoaffective disorder.

Our Research

At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.

EXPLORE OUR RESEARCH

Stay in the Know

Sign up for compelling stories about innovative science, the doctors and researchers who turn ideas into discoveries and treatments, and the kids and families whose lives are changed.

This field is for validation purposes and should be left unchanged.